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Purpose: To evaluate radiological findings of non-calcified
ductal carcinoma in situ (DCIS) and to correlate those with
histological features. Materials and Methods: From July 2002
to March 2006, 22 patients with histologically-proven non-
calcified DCIS were included. Mammography was obtained in
19 patients, ultrasound in 18 patients, and both examinations
in 15 patients. Radiological findings were evaluated according
to the Breast Imaging Reporting and Data System by American
College of Radiology. Histological tumor subtype and Van
Nuys classification of DCIS were assessed. Results: Histological
subtypes consisted of mixed type in 11 patients (50%), comedo
in 4 (18%), cribriform in 4 (18%), papillary type in 2 (9%),
and solid in one (5%). According to Van Nuys classification,
group 3 DCIS was observed in 13 (59%) patients. In the 19
patients who underwent mammography, 13 patients presented
with abnormal findings: focal asymmetry in 7 patients (37%),
masses in 4 (21%), skin thickening in one (5%), and
architectural distortion in one (5%). In the 18 patients who had
received breast ultrasound, a mass was present in 15 (83%)
patients and ductal changes in 3 patients (17%). Sixty percent
of patients with masses on ultrasound had group 3 DCIS and
100% of patients with ductal change had group 1 DCIS (p =
0.017). Conclusion: Diagnosis of non-calcified DCIS by
mammography is not an easy task due to the lack of typical
malignant calcifications or masses. High resolution ultrasound
can be useful for detecting non-calcified DCIS, and ultrasound
findings are correlated with histological features.
Key Words: Breast neoplasms, noninfiltrating intraductal
carcinoma, mammography, mammary ultrasonography
INTRODUCTION
For breast cancer screening, self-examination,
clinical examination, and mammography have all
been used for the past 20 - 30 years. Interestingly,
the proportion of all breast cancers discovered
because of ductal carcinoma in situ (DCIS) has
increased due to the use of mammography,
reaching 20 - 30% in screening groups.
1-4
DCIS of the breast is defined as proliferation of
malignant epithelial cells within ducts without
evidence of invasion or infiltration through the
basement membrane into the surrounding stroma,
3
and has a much better prognosis than invasive
cancers. Indeed, in a large population-based
surveillance, epidemiology, and end results series,
Ernster et al.
5 reported a 10-year mortality risk of
DCIS of only 1.9%. Therefore, early detection of
DCIS is essential for improving the prognosis of
breast cancer.
The typical mammographic finding of DCIS is
microcalcifications, however, approximately 10 -
20% of DCIS cases manifest with non-calcified
lesions.
1,6,7 In addition, 16% of DCIS are occult on
mammography.
6,8 Thus, additional imaging moda-
lities beside mammography are needed for detec-
tion of non-calcified DCIS.
Breast ultrasound (US) has widely been used as
a supplementary modality for evaluating mam-
mographically detected abnormalities and is an
effective screening modality for detecting occult
breast cancers in mammographically determined
dense breasts.
9-12 Indeed, US has a high sensitivity
and negative predictive value for diagnosing
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breast cancer
13 and, thanks to the added use of
high resolution sonographic equipment, the
characteristics of breast lesions can be depicted
more clearly than ever before.
To the best of our knowledge, there have been
only a few reports about the radiological findings
of non-calcified DCIS, especially using breast
US.
14,15 Therefore, we evaluated radiological
findings of non-calcified DCIS using mammography
and US and correlated the radiological findings
with histological features.
MATERIALS AND METHODS
The institutional review board at the Korea
University Anam Hospital approved this study.
Using a computer database system, we searched
for and recruited patients who underwent
surgical treatment of primary breast cancers at
our institute from July 2002 to March 2006. A
total of 657 consecutive patients with primary
breast carcinomas were evaluated for enrollment
in this study, and 137 patients (21%) had pure
DCIS on pathological examination. Among the
137 DCIS patients, 22 patients (16%) who had no
microcalcifications on radiological and his-
tological examinations were included in this
study. 14 of 22 patients underwent conservation
breast surgery and the remaining 8 patients
underwent simple mastectomy. Sentinel lymph
node biopsy was performed in 3 patients and the
status of axillary nodes was negative, therefore,
axillary dissection was not performed. All
patients were female, ranging from 32 to 85
years of age (mean 50 years). Among the 22
patients, preoperative mammography data were
available for 19 patients, US images for 18, and
both for 15.
For mammography, we used a Senographe-
DMR+ mammography unit (General Electronic
Medical System, Milwaukee, WI, U.S.A.) or a
Selenia IV (Lorad, Bedford, CT, USA). We
evaluated routine craniocaudal and mediolateral
oblique views, as well as additional views
including magnification, spot compression, and so
on in a dark room with a magnifying glass.
For US, we used a Logiq9 US unit (General
Electronic Medical System) with a high frequency
linear scanhead (14 - 5 MHz). We routinely
scanned whole breasts and obtained transverse,
longitudinal, and radial views of each lesion.
An expert breast radiologist (K.R.C) retrospec-
tively evaluated mammography and breast US
images. Mammographic findings were divided
into mass, focal asymmetry, architectural distortion,
or others. Other division categories included skin
change, nipple change, or axillary lymphadeno-
pathy. In cases where masses were visible on
mammography, the shape, margin, and density of
the masses were evaluated according to the Breast
Imaging Reporting and Data System (BI-RADS )
atlas.
16 US findings were divided into mass or
ductal change. A mass occupies space and should
be seen in two different projections. When the
lesion did not exactly correspond to the definition
of a mass change, but rather to echo-filled
distended ducts, we defined the lesion as a ductal
change. In cases where masses were found with
US, the shape, margin, echo pattern, posterior
acoustic features, and orientation were evaluated
according to the BI-RADS .
16
An experienced pathologist (C.H.K.) evaluated
the histological tumor subtype and Van Nuys
classification of all 22 patients. Tumor subtypes
were divided into comedo, cribriform, papillary,
micropapillary, or solid type according to the
guidelines set by the Consensus Conference
Committee.
17 Lesions with mixtures of various
subtypes were defined as mixed subtypes. Van
Nuys classification of DCIS was divided into
group 1 (nonhigh grade DCIS without comedo-
type necrosis), group 2 (nonhigh grade DCIS with
comedo-type necrosis), or group 3 (high grade
DCIS with or without comedo-type necrosis).
18,19
The statistical analysis for correlation between
radiological findings and histological features was
performed by Fisher’s exact test (SAS/STAT
software,version 6.12; SAS Institute, Cary, NC,
USA). P values lower than 0.05 were considered
statistically significant.
RESULTS
Table 1 summarizes clinical, radiological, and
histological findings of all 22 patients with non-
calcified DCIS. Histological subtypes consisted ofRadiological and Histological Findings of Non-Calcified DCIS
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mixed type in 11 patients (50%), comedo in 4
(18%), cribriform in 4 (18%), papillary type in 2
(9%), and solid in one (5%). According to Van
Nuys classification, group 3 DCIS was observed in
13 (59%) patients, group 2 in 4 (18%), and group
1 in 5 (23%). All 4 (100%) comedo subtypes and
9 (82%) of the 11 mixed subtypes displayed group
3. A total of 14 (64%) of the 22 patients had
clinical symptoms: palpable masses in 11 patients
and nipple discharge in 3. The 14 patients with
clinical symptoms had a more frequent rate of
group 3 DCIS (9/14, 64%) than patients without
symptoms (4/8, 50%).
In 19 patients who received a mammography
examination, 13 (68%) patients presented with
abnormal findings, namely, focal asymmetry in 7
patients (37%) (Fig. 1), masses in 4 (21%), skin
thickening in one (5%), and architectural distor-
tion in one (5%) (Table 1). Of the 4 patients with
masses visible on mammography, 2 patients had
non-circumscribed irregular masses and the
remaining 2 patients had circumscribed oval
masses. We were unable to detect abnormalities in
the remaining 6 (32%) patients, 5 of which had
dense breast tissues (Fig. 2) while the other had
scattered fibroglandular tissues (Fig. 3). Among
these 6 patients, 2 (33%) had group 3 DCIS on
histological examination. Four (57%) of 7 patients
with focal asymmetry on mammography had
group 3 DCIS, while 3 (75%) of 4 patients with
masses had group 3 DCIS. However, there was no
statistical significance between mammographic














1 47 Palpable mass Focal asymmetry Ductal change Cribriform Group 1
2 36 Palpable mass Focal asymmetry Mass Mixed Group 3
3 60 Palpable mass Focal asymmetry Not available Comedo Group 3
4 45 None Focal asymmetry Ductal change Cribriform Group 1
5 35 Palpable mass Focal asymmetry Mass Comedo Group 3
6 51 None Focal asymmetry Not available Mixed Group 3
7 50 Palpable mass Focal asymmetry Mass Mixed Group 2
8 42 Palpable mass None Mass Mixed Group 3
9 45 None None Mass Papillary Group 1
10 38 None None Mass Mixed Group 3
11 41 None None Mass Mixed Group 2
12 45 Bloody discharge None Ductal change Cribriform Group 1
13 42 Palpable mass None Mass Cribriform Group 1
14 48 Palpable mass Circumscribed oval mass Mass Solid Group 1
15 50 Palpable mass Spiculated irregular mass Mass Comedo Group 3
16 55 Palpable mass Circumscribed oval mass Mass Mixed Group 3
17 82 None Indistinct irregular mass Not available Mixed Group 3
18 58 None Skin thickening Not available Comedo Group 3
19 61 Bloody discharge Architectural distortion Mass Mixed Group 3
20 45 None Not available Mass Papillary Group 1
21 41 Palpable mass Not available Mass Mixed Group 3
22 81 Bloody discharge Not available Mass Mixed Group 3
*Van Nuys classification of DCIS is divided into group 1 (nonhigh grade DCIS without comedo-type necrosis), group 2
(nonhigh grade DCIS with comedo-type necrosis), and group 3 (high grade DCIS with or without comedo-type necrosis).Kyu Ran Cho, et al.
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findings and Van Nuys classification (p = 0.811).
In 18 patients who had received breast US, a
mass change was present in 15 (83%) patients
(Figs. 1 and 2) and ductal changes in 3 (17%)
remaining patients (Table 1) (Fig. 3). Nine (60%)
of 15 patients with masses on breast US had
group 3 DCIS. Conversely, all 3 patients with
ductal change on US had group 1 cribriform
DCIS. A mass was more frequently associated
with group 3 DCIS, and ductal change was with
group 1 DCIS (p = 0.017). Table 2 presents the
characteristics of 15 masses evaluated with breast
US, and Table 3 demonstrates a correlation between
US findings and Van Nuys classification of these
masses. Non-circumscribed margins (11/15, 73%)
including indistinct, microlobulated, or spiculated
margins were more frequent than circumscribed
margins (4/15, 27%). Indistinct margins were
observed in 8 patients (44%); this was the most
common margin observed in non-calcified DCIS.
Group 3 DCIS was more common in masses with
non-circumscribed margins (9/11, 82%) than
masses with circumscribed margins (1/4, 25%).
Most of the DCIS cases had a hypoechoic or
complex echo pattern (12/15, 80%) and parallel
orientation (13/15, 87%). The two non-parallel
oriented masses were group 3 DCIS. The shapes
and posterior acoustic features of non-calcified
DCIS varied.
Fig. 1. (Patient No. 5) A 35-year-old woman with a
palpable mass in left breast and group 3 DCIS of Van
Nuys classification (A) Mammography shows a focal
asymmetry (arrows) in the left upper outer quadrant,
palpable mass site. (B) Transverse (left) and longitudinal
(right) scans of US reveal a microlobulated marginated,
irregular shaped, hypoechoic mass (arrows). The mass
has parallel orientation and an unaffected posterior
acoustic feature.
Fig. 2. (Patient No. 8) A 42 -year-old woman with a
palpable mass in the right breast and group 3 DCIS of
Van Nuys classification. (A) Right mammography shows
no detectable lesion. (B) Transverse scan of US
demonstrates an indistinct marginated, oval shaped,
hypoechoic mass (arrows) in the lower mid portion of
right breast, palpable mass site. The mass has parallel
orientation and an unaffected posterior acoustic feature.
A
B A
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DISCUSSION
DCIS is mostly detected during screening
mammography, because clinical symptoms are
present in only 10 - 24% of DCIS patients.
19 While
the most common feature of mammography-
detected DCIS is microcalcification, the focus of
our present study was on non-calcified DCIS.
Ikeda and Andersson6 reported that 60 (82%) out
of 73 patients with non-calcified DCIS are
symptomatic. In agreement with the about results
of Ikeda and Andersson, we found that 64% of
non-calcified DCIS patients were symptomatic:
50% palpable masses and 14% nipple discharge. In
our clinical practice, we routinely performed
breast US with or without mammography if a
patient had a breast palpable mass. If the mass
had suspicious malignant feature on physical
examination, a physician tried to perform fine
needle aspiration or core biopsy. When the
cytological result after fine needle aspiration was
inadequate to decide histological diagnosis,
Table 2. US Characteristics of 15 Non-Calcified DCIS Presenting as Masses
US findings Characteristics No. of patients (%)
Shape Round or oval 8 (53)
Irregular 7 (47)




Echo pattern Hypoechoic 6 (40)
Complex 6 (40)
Isoechoic 3 (20)




Orientation to skin Parallel 13 (87)
Not parallel 2 (13)
Fig. 3. (Patient No. 12) A 45-year-old woman with left
bloody discharge and group 1 DCIS of Van Nuys
classification. (A) Mammography shows no detectable
abnormal finding. (B) Transverse scan of US depicts
ductectasia with intraductal solid components (arrows) in
the central portion of the left breast. A
B
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imaging-guided core needle biopsy or excisional
biopsy was performed. When the histological
result after core biopsy was high risk breast
lesions (i.e. atypical ductal hyperplasia or radial
scar) or DCIS, we performed surgical excision for
final histological diagnosis. In cases with nipple
discharge, we performed both mammography and
breast US. Galactography or breast MRI would be
considered, if there was no abnormal finding on
mammography and US. In 22 patients of the
current study, initial histological diagnoses in 17
patients were obtained by core needle biopsy,
excisional biopsy in 4 patients, and fine-needle
aspiration in one patient and then surgery was
performed in all 22 patients. Sixty four percent of
non-calcified DCIS patients were symptomatic in
this study, therefore, physician should evaluate
the patients who have clinical symptoms with
more attention.
Histological nuclear grades and presence of
comedo necrosis in DCIS are important for
predicting a prognosis. Van Nuys classification
was made using both nuclear grade and presence
of comedo necrosis, and DCIS cases were divided
into group 1, 2 or 3.
18,19 Group 3 DCIS has both
high nuclear grade and comedo necrosis. In
calcified DCIS, linear branching or pleomorphic
microcalcifications have a high predictive value
for the high-grade comedo type.
20 On the other
hand, there have been only a few reports showing
the histological feature in non-calcified DCIS, the
results of which are controversial. In the present
study we found that 13 (59%) of 22 patients had
group 3 DCIS. With respect to tumor subtype,
mixed type was the most common (50%) in
non-calcified DCIS, whereas comedo type (18%)
and cribriform type (18%) were the second most
common non-calcified DCIS. However, the
number of patients enrolled in many previous
studies on this topic has been too small to analyze
statistical significance. Therefore, further study is
needed to confirm characteristic histological
feature of non-calcified DCIS in a large population
In this study, we evaluated radiological findings
using both mammography and US. At 37%, focal
asymmetries were the most common finding on
mammography, followed by masses at 21%, and
no lesions at 32%. A focal asymmetry differs from
a mass since it usually lacks convex outward
borders and contains interspersed fat.
16 Thus,
radiologists should examine mammography in
detail and distinguish a focal asymmetric density
Table 3. Correlation between US Findings and Van Nuys Classification in 15 Non-Calcified DCIS Presenting as Masses
US findings Characteristics
Van Nuys classifications
Group 1 Group 2 Group 3
Shape Round or Oval 2 2 4
Irregular 2 5




Echo pattern Hypoechoic 1 5
Complex 2 1 3
Isoechoic 2 1
Posterior acoustic feature Unaffected 1 2 3
Enhanced 1 1 2
Combined 1 2
Shadowing 2
Orientation to skin Parallel 2 4 7
Not parallel 2Radiological and Histological Findings of Non-Calcified DCIS
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from asymmetric breast tissue. If such a lesion is
suspected, physicians should not hesitate to
perform a biopsy.
In the present study, 6 (32%) of the non-
calcified DCIS cases could not be detected on
mammography. Five (83%) out of six DCIS
patients with no mammographical lesions had
dense breast tissues on mammography, while the
other patient exhibited scattered fibroglandular
tissues. Previous studies demonstrated that 6 - 23
% of overall DCIS cases were mammographically
occult.
6-8 These 6 patients presented five masses
and one instance of ductal change according to
breast US. For this reason, breast US was the only
modality able to detect the lesion. Thus, breast US
should be considered as a screening modality for
the detection of non-calcified DCIS in women
with dense breast tissues on mammography.
In the current study, 15 (83%) of 18 patients
who received breast US presented with masses,
while 3 patients presented with ductal change
(17%). Common findings of the masses included
an indistinct margin, hypoechoic or complex
echoic patterns, and a parallel orientation. Our US
findings were similar to previous studies by Moon
et al.
15 and DiPiro et al.
14 who evaluated overall
DCIS cases, calcified and non-calcified. Typical
malignant features, including spiculation or
shadowing, were not frequent in DCIS. Indistinct
margins and hypoechoic or complex echo patterns
are suspicious findings in the diagnosis of breast
malignancy; however, round or oval shape and
unaffected posterior acoustic features are not.
Thus, if a mass has one more suspicious malignant
findings by breast US, a biopsy should be per-
formed in order to diagnose possible non-calcified
DCIS.
There have been several studies outlining the
ductal changes that occur in DCIS. Moon et al.
15
demonstrated that multiple small intraductal
nodules are rare presentation of DCIS, especially
in patients with nipple discharge, and Yang and
Tse
21 reported that 23% of symptomatic DCIS can
be depicted as ductal dilatations. In the present
study, patients with ductal changes presented
single or multiple tumor-filled ductal dilatations
on US. On histological examination, there were
intraductal and/or periductal tumor cell infiltra-
tions with minor periductal fibrosis. According to
the current BI-RADS-Ultrasound lexicon, ductal
change is defined as an abnormal caliber and/or
arborization; there is no mention of intraductal
nodules. Therefore, we hope that the findings in
this study will prompt to reevaluate the description
of ductal change in the current BI-RADS-
Ultrasound lexicon.
In conclusion, most non-calcified DCIS patients
have clinical symptoms and group 3 DCIS of Van
Nuys classification. Such cases commonly present
a focal asymmetry on mammography, and occult
cases are not uncommon. High resolution US can
be useful for detecting non-calcified DCIS when
the lesion cannot fully be assessed by mammo-
graphy. In addition, US findings are correlated
with histological features. However, the number
of patients was too small to statistically analyze.
Thus, further studies are needed to confirm the
correlation between US findings and histological
features in patients with non-calcified DCIS.
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